Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study

NCT00539448 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: insulin glargine
DRUG: insulin glulisine

Sponsor

Sanofi